Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biocardia Inc

BCDA
Current price
0.66 USD +0.026 USD (+4.13%)
Last closed 0.63 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 15 879 322 USD
Yield for 12 month -63.96 %
Week
Month
Year
BCDA
21.11.2021 - 28.11.2021

BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California. Address: 320 Soquel Way, Sunnyvale, CA, United States, 94085

Analytics

WallStreet Target Price

4 USD

P/E ratio

Dividend Yield

1.93 %

Current Year

+1 352 000 USD

Last Year

+1 015 000 USD

Current Quarter

+357 000 USD

Last Quarter

+43 000 USD

Current Year

-10 549 000 USD

Last Year

+1 015 000 USD

Current Quarter

+357 000 USD

Last Quarter

+43 000 USD

Key Figures BCDA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -12 493 000 USD
Operating Margin TTM -727.73 %
PE Ratio
Return On Assets TTM -121.64 %
PEG Ratio
Return On Equity TTM -728.95 %
Wall Street Target Price 4 USD
Revenue TTM 570 000 USD
Book Value -0.031 USD
Revenue Per Share TTM 0.028 USD
Dividend Share
Quarterly Revenue Growth YOY 68.4 %
Dividend Yield 1.93 %
Gross Profit TTM -7 482 000 USD
Earnings Share -0.62 USD
Diluted Eps TTM -0.62 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BCDA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BCDA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 1.93 %
Last Split Factor 1:9
Payout Ratio
Last Split Date 06.06.2019
Dividend Date 06.06.2019

Stock Valuation BCDA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 27.0918
Price Sales TTM 27.8585
Enterprise Value EBITDA -1.2361
Price Book MRQ 10.6661

Financials BCDA

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators BCDA

For 52 weeks

0.36 USD 2.92 USD
50 Day MA 0.49 USD
Shares Short Prior Month 132 675
200 Day MA 1.43 USD
Short Ratio 0.02
Shares Short 150 544
Short Percent 0.84 %